首页> 外国专利> 12443-a BET Novel 124triazolo43-aquinoxaline amino phenyl derivatives or pharmaceutically acceptable salts thereof preparation method therof and pharmaceutical composition for use in preventing or treating bromodomain extra-terminalBET protein activity related diseases containing the same as an active ingredient

12443-a BET Novel 124triazolo43-aquinoxaline amino phenyl derivatives or pharmaceutically acceptable salts thereof preparation method therof and pharmaceutical composition for use in preventing or treating bromodomain extra-terminalBET protein activity related diseases containing the same as an active ingredient

机译:[124] [43-a] BET新型[124]三唑并[43-a]喹喔啉氨基苯基衍生物或其药学上可接受的盐的制备方法和用于预防或治疗与溴结构域末端BET蛋白活性有关的疾病的药物组合物与有效成分相同

摘要

The present invention relates to a [1,2,4] triazolo [4,3-a] quinolizinaminophenyl derivative or a pharmaceutically acceptable salt thereof, a process for preparing the same, and a bromodomain extra- And a pharmaceutical composition for preventing or treating a protein-related disease. The [1,2,4] triazolo [4,3-a] quinolizine aminophenyl derivative according to the present invention excellently inhibits the binding of BRD4 protein, one of the BET protein family, at low concentration, Therefore, it can be useful for preventing or treating diseases related to BET protein, particularly cancer or autoimmune diseases.
机译:本发明涉及[1,2,4]三唑并[4,3-a]喹啉嗪氨基苯基衍生物或其药学上可接受的盐,其制备方法和溴结构域额外的化合物以及用于预防或治疗的药物组合物与蛋白质有关的疾病。根据本发明的[1,2,4]三唑并[4,3-a]喹啉嗪氨基苯基衍生物在低浓度下能极好地抑制BET蛋白家族之一的BRD4蛋白的结合,因此可用于预防或治疗与BET蛋白有关的疾病,尤其是癌症或自身免疫性疾病。

著录项

  • 公开/公告号KR101995533B1

    专利类型

  • 公开/公告日2019-07-02

    原文格式PDF

  • 申请/专利权人 한국화학연구원;

    申请/专利号KR20170035176

  • 发明设计人 이광호;최길돈;알리 임란;

    申请日2017-03-21

  • 分类号C07D487/04;A23L33/10;A61K31/4985;

  • 国家 KR

  • 入库时间 2022-08-21 11:48:14

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号